Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Beneficial effects of the selective CO-stimulation modulator abatacept on biomarkers of rheumatoid arthritis immunopathology in patients with an inadequate response to methotrexate or TNF-inhibitor treatment Annual European Congress of Rheumatology Emery, R., Westhovens, R., LEON, G., Nuamah, I., Ge, Z., Aranda, R., Becker, J., Genovese, M., Dougados, M. BMJ PUBLISHING GROUP. 2005: 432–433
View details for Web of Science ID 000229909102097